Abstract
Bax inhibitor-1 (BI-1) is an evolutionarily-conserved endoplasmic reticulum protein. The expression of BI-1 in mammalian cells suppresses apoptosis induced by Bax, a pro-apoptotic member of the Bcl-2 family. BI-1 has been shown to be associated with calcium (Ca2+) levels, reactive oxygen species (ROS) production, cytosolic acidification, and autophagy as well as endoplasmic reticulum stress signaling pathways. According to both in vitro and clinical studies, BI-1 promotes the characteristics of cancers. In other diseases, BI-1 has also been shown to regulate insulin resistance, adipocyte differentiation, hepatic dysfunction and depression. However, the roles of BI-1 in these disease conditions are not fully consistent among studies. Until now, the molecular mechanisms of BI-1 have not directly explained with regard to how these conditions can be regulated. Therefore, this review investigates the physiological role of BI-1 through molecular mechanism studies and its application in various diseases.
Keywords: Bax inhibitor-1, ER stress, lysosome, reactive oxygen species, unfolded protein response.
Current Molecular Medicine
Title:The Characteristics of Bax Inhibitor-1 and its Related Diseases
Volume: 14 Issue: 5
Author(s): B. Li, R.K. Yadav, G.S. Jeong, H.-R. Kim and H.-J. Chae
Affiliation:
Keywords: Bax inhibitor-1, ER stress, lysosome, reactive oxygen species, unfolded protein response.
Abstract: Bax inhibitor-1 (BI-1) is an evolutionarily-conserved endoplasmic reticulum protein. The expression of BI-1 in mammalian cells suppresses apoptosis induced by Bax, a pro-apoptotic member of the Bcl-2 family. BI-1 has been shown to be associated with calcium (Ca2+) levels, reactive oxygen species (ROS) production, cytosolic acidification, and autophagy as well as endoplasmic reticulum stress signaling pathways. According to both in vitro and clinical studies, BI-1 promotes the characteristics of cancers. In other diseases, BI-1 has also been shown to regulate insulin resistance, adipocyte differentiation, hepatic dysfunction and depression. However, the roles of BI-1 in these disease conditions are not fully consistent among studies. Until now, the molecular mechanisms of BI-1 have not directly explained with regard to how these conditions can be regulated. Therefore, this review investigates the physiological role of BI-1 through molecular mechanism studies and its application in various diseases.
Export Options
About this article
Cite this article as:
Li B., Yadav R.K., Jeong G.S., Kim H.-R. and Chae H.-J., The Characteristics of Bax Inhibitor-1 and its Related Diseases, Current Molecular Medicine 2014; 14 (5) . https://dx.doi.org/10.2174/1566524014666140603101113
DOI https://dx.doi.org/10.2174/1566524014666140603101113 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Curcumin Suppresses Epithelial Growth Factor Receptor (EGFR) and Proliferative Protein (Ki 67) in Acute Lung Injury and Lung Fibrosis <i>In vitro</i> and <i>In vivo</i>
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Platelets in Angiogenesis in Health and Disease
Current Angiogenesis (Discontinued) α 2-Adrenoceptor Antagonist SL84.0418 Involvement in the Development of Opioid Withdrawal
Letters in Drug Design & Discovery Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Heart Failure in South America
Current Cardiology Reviews Synergic Study of α-Glucosidase Inhibitory Action of Aloin and its Antioxidant Activity with and without Camel β-Casein and its Peptides
Protein & Peptide Letters Blood microRNA-15a Correlates with IL-6, IGF-1 and Acute Cerebral Ischemia
Current Neurovascular Research Potential of Liposomes for Enhancement of Oral Drug Absorption
Current Drug Delivery Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients
Current Pharmacogenomics Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review
Current Medicinal Chemistry Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Current Cancer Drug Targets Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease
CNS & Neurological Disorders - Drug Targets New Convenient Approach for the Synthesis of Benzyl 2H-Chromenones and their α-Amylase Inhibitory, ABTS.+ Scavenging Activities
Medicinal Chemistry Periodontal Regenerative Materials and Their Applications: Goodness of Fit?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Antidiabetic Effect of Spearmint in Streptozotocin-Induced Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Ischemic Neuronal Damage
Current Pharmaceutical Design Preface
Current Pharmaceutical Design Biosimilars for the Management of Inflammatory Bowel Diseases: Economic Considerations
Current Medicinal Chemistry Sexual Dimorphism in Autoimmune Disease
Current Molecular Medicine Effect of Adding Proprioceptive Exercise to Balance Training in Older Adults with Diabetes: A Systematic Review
Current Diabetes Reviews